• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Distribution

BD inks UAE insulin pen distro deal with Julphar

August 28, 2018 By Fink Densford

Becton Dickinson, Julphar

Pharmaceutical manufacturer Julphar said yesterday it inked a deal with BD (NYSE: BDX) to supply disposable insulin pens to the United Arab Emirates. Through the deal, individuals will be able to purchase BD’s Vystra disposable pens featuring Julphar’s human insulin formulations, including its Jusline R, Jusline N and Jusline 30/70. The same system is slated to be […]

Filed Under: Business/Financial News, Diabetes, Distribution, Drug-Device Combinations, Featured Tagged With: Becton Dickinson, julphar

Valeritas inks distro deal for V-Go device in Austria, Germany

May 21, 2018 By Sarah Faulkner

Valeritas

Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Med Trust to commercialize its V-Go insulin delivery device in Austria and Germany. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, quality management and manufacturing. Med Trust will take over the sales, marketing and distribution activities […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Valeritas Inc.

Report: Amazon abandons drug distribution and supply plans

April 18, 2018 By Fink Densford

Amazon

Amazon‘s (NSDQ:AMZN) Business division has dropped plans to sell and distribute pharmaceutical products to hospitals, according to a new report from CNBC. The shift comes due to the online mega-retailer being unable to convince large hospital groups to change their purchasing process and break existing deals and relationships with distributors, according to the report. The […]

Filed Under: Business/Financial News, Distribution, Featured, Pharmaceuticals Tagged With: amazon

Valeritas inks distro deal in Australia, New Zealand for V-Go insulin delivery device

April 17, 2018 By Sarah Faulkner

Valeritas V-Go device

Valeritas (NSDQ:VLRX) said today that it inked an exclusive distribution deal with AMSL Diabetes and NZMS Diabetes for the commercialization of its V-Go wearable insulin delivery device in Australia and New Zealand. According to the terms of the agreement, AMSL Diabetes and NZMS Diabetes retain the right to promote, market and sell the V-Go device to clinics and […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Valeritas Inc.

Tandem inks distro deal in Italy for insulin pump

April 9, 2018 By Sarah Faulkner

Tandem Diabetes

Tandem Diabetes Care (NSDQ:TNDM) has signed a distribution deal with Movi SpA to commercialize Tandem’s t:slim X2 insulin pump in Italy. The San Diego, Calif.-based company said today that Movi is slated to run sales, marketing and customer training for Tandem’s products in Italy, according to the terms of the agreement. “Partnering with experienced insulin pump […]

Filed Under: Diabetes, Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Tandem Diabetes Care

Reva inks distro deal for bioresorbable scaffolds in Turkey

April 3, 2018 By Sarah Faulkner

Reva Medical

Reva Medical (ASX:RVA) inked a distribution deal with Kardionet Healthcare & Foreign Trading to launch commercial operations in Turkey for its bioresorbable scaffold tech, the company reported today. According to the terms of the deal, Kardionet will be responsible for sales, marketing, customer training and support for Reva’s Fantom and Fantom Encore bioresorbable devices in Turkey. […]

Filed Under: Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Vascular, Wall Street Beat Tagged With: Reva Medical

Smiths Medical inks distro deal for infusion therapy products

March 6, 2018 By Sarah Faulkner

Smiths Medical

Smiths Medical plans to distribute its CADD infusion systems to non-hospital-based providers through a preferred partnership with Medical Specialties Distributors, the company reported today. As part of its new distribution model, Smiths will also make its infusion pumps and sets available to providers outside of the hospital setting through InfuSystem (NYSE:INFU) and Integrated Medical Systems. The […]

Filed Under: Distribution, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: infusystem, Smiths Medical

Lenis inks distribution deal for needle-free injection system

January 23, 2018 By Sarah Faulkner

Lenis

Lenis Medical and Premier Distributing have inked an exclusive distribution deal for the U.S. sales of its needle-free injection system. Lenis’ high-velocity, spring-loaded device injects medication painlessly into the skin, according to the company. Lenis touted its system as being universally applicable to subcutaneous and intramuscular medications, including steroids, insulin, vaccines and orthopedic drugs. The […]

Filed Under: Distribution, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: lenis

Reva Medical pursues direct-sales after Boston Scientific distro negotiation deal lapses

August 4, 2017 By Fink Densford

Reva Medical, Boston Scientific

Reva Medical (ASX:RVA) said today it will take up direct marketing of its peripheral and vascular scaffolds after Boston Scientific‘s (NYSE:BSX) right to negotiate for exclusive distribution of the products expired. San Diego, Calif.-based Reva said that Boston Scientific had gained the right to negotiate for exclusive distribution rights under a 2007 agreement which would have positioned […]

Filed Under: Business/Financial News, Distribution, Stents Tagged With: Boston Scientific, Reva Medical

Medtech stories we missed this week: May 12, 2017

May 12, 2017 By Danielle Kirsh

missed medtech

From Bioness’s new distribution deal to InBrace’s launch of new braces technology, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Obalon receives approval to commercialize in Middle East Obalon Therapeutics announced in a May 11 press release that it has received regulatory approvals in select Middle East […]

Filed Under: Business/Financial News, Distribution, Featured, Patient Monitoring, Regulatory/Compliance Tagged With: Bioness Inc., InBrace, LensAR Inc., medtech, Obalon Therapeutics, Ottobock, SRS Medical, Teleon Surgical, ZipLine Medical

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS